23
Cardiac Hepatopathy : Clinical , Hemodynamic , and Histologic Characteristic s and Correlations HEPATOLOGY 2003 ; 37: 393-400 Robert P. Myers, Raimondo Cerini, Raymon d Sayegh, Richard Moreau, Claude Degott, Didier Lebrec, and Samuel S. Lee

Cardiac hepatopathy.ppt

Embed Size (px)

Citation preview

Page 1: Cardiac hepatopathy.ppt

Cardiac Hepatopathy : Clinical , Hemodynamic , andHistologic Characteristics and

Correlations

HEPATOLOGY 2003 ; 37: 393-400

Robert P. Myers, Raimondo Cerini, Raymond Sayegh, Richard Moreau, Claude Degott, Didier Lebrec,

and Samuel S. Lee

Page 2: Cardiac hepatopathy.ppt

Patients and Methods

1980-2001The first 63 patients were reviewed retrospectively whereas the remaining 30 were studied in a prospective fashion. All patients were referred for hepatic vein catheterization studies and/or transjugular liver biopsy to investigate hepatic dysfunction or disease.

Page 3: Cardiac hepatopathy.ppt

Patients and MethodPatients are divided into 3 groups based on the duration of their cardiac disease:

(1) acute: symptoms less than 2 weeks duration and no prior cardiac disease

(2) chronic: known, compensated cardiac disease(3) acute on chronic: prior cardiac disease with acute deco

mpensation over the preceding 2 weeks. Underlying cardiac diagnoses were classified as cardiomyopathy (e.g., acute myocardial infarction), valvular (e.g., rheumatic heart disease), hemorrhagic shock, pericardial (e.g., constrictive pericarditis), pulmonary (e.g., cor pulmonale due to chronic pulmonary disease), or mixed.

Page 4: Cardiac hepatopathy.ppt

Diagnostic criteria :

(1) a liver biopsy compatible with cardiac hepatopathy(2) at least one of the following abnormal hemodynamic measurements:

right atrial pressure (RAP) greater than 10 mm Hgmean pulmonary arterial pressure greater than 25 mm H

gpulmonary capillary wedge pressure greater than 15 mm

Hg cardiac index less than 2.2 L/min m2

(3) clinically overt circulatory shock or congestive heart failure.

Additional causes of liver disease including hepatitis B infection, autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, hemochromatosis,Wilson disease, and 1-antitrypsin deficiency were excluded. Patients with excessive alcohol consumption (30 g/d in women and 50 g/d in men) also were excluded.

Page 5: Cardiac hepatopathy.ppt

Patients and Methods

All patients had been recorded:free hepatic venous pressure (FHVP)wedged hepatic venous pressure (WHVP)RAP

The hepatic venous pressure gradient (HVPG), which is correlated closely with the intrahepatic contribution to portal pressure, was calculated as the difference between the WHVP and FHVP.

Page 6: Cardiac hepatopathy.ppt

Statistical Analysis

priori hypothesespatients with abnormal architecture would have elevated hepatic venous pressures and HVPG, reflective of increased portal pressure, and those with sinusoidal dilatation would have elevated FHVP and RAP 1-sided tests were used for these comparisons P value < .05 was considered statistically significant.

Page 7: Cardiac hepatopathy.ppt
Page 8: Cardiac hepatopathy.ppt
Page 9: Cardiac hepatopathy.ppt

Discussion-- biochemistry

The most striking biochemical feature of this disorder was a marked elevation of the aminotransferase levels, often greater than 2,000 IU/L, particularly in patients with acute cardiac dysfunction. In the chronic group, the aminotransferases, were elevated only minimally. The alkaline phosphatase concentration was increased modestly.With respect to tests of liver function per se, abnormalities in cardiac hepatopathy were moderate.However, significant elevations in bilirubin and prothrombin time were seen, particularly in patients with acute cardiac dysfunction.

Page 10: Cardiac hepatopathy.ppt
Page 11: Cardiac hepatopathy.ppt

Discussion — clinical presentation

Many patients in all groups presented with signs of portal hypertension and jaundice.Ascites and edema had no relation to the extent of hepatic damage, and are likely a function of elevated right-sided cardiac pressures. The frequency of ascites and jaundice may reflect some selection bias, but nonetheless, these were not uncommon modes of presentation.Indeed, the presenting clinical features of several patients were indistinguishable from typical noncardiac liver diseases, such as alcohol-induced hepatitis or cirrhosis. Only on hemodynamic testing did the correct diagnosis become apparent, underscoring the importance of a high index of suspicion for cardiac causes of liver disease, particularly in patients with a history of cardiac dysfunction

Page 12: Cardiac hepatopathy.ppt
Page 13: Cardiac hepatopathy.ppt

Discussion -- hemodynanics

In this series, the hemodynamic patterns were distinct and virtually pathognomonic in the case of right heart or biventricular failure. Backward failure, as reflected in high right atrial pressure, was transmitted clearly to the hepatic and portal venous circulations, resulting in a tracing of the WHVP that often was pulsatile instead of the usual flat line. It has been shown that WHVP reflects the portal pressure, whereas the HVPG reflects the intraparenchymal (sinusoidal) contribution to portal pressure. Despite frequently elevated WHVP, caused by elevated FHVP, the HVPG was normal in the majority (81%) of our patients.We did not find this observation of normal HVPG in cardiac hepatopathy reported in the English-language literature.

Page 14: Cardiac hepatopathy.ppt

Systemic Hemodynamics vs Biochemistry

In 65 pediatric patients with congenital heart disease, Mace et al. found several correlations suggesting that biochemical abnormalities are associated with the severity of heart failure, findings confirmed in adults with stable, dilated cardiomyopathy. We found similar results in our patients with acute cardiac dysfunction, in whom the aminotransferases were correlated strongly and positively with the right-sided cardiac and hepatic venous pressures.This finding mirrors the common clinical scenario of the patient presenting with acute heart failure and markedly elevated aminotransferase levels.

Page 15: Cardiac hepatopathy.ppt

Systemic Hemodynamics vs Biochemistry

In contrast to previous reports, we did not find significant associations between liver biochemistry and the severity of cardiac dysfunction in patients with chronic disease.With respect to other liver biochemical tests including ALP, bilirubin, PT, and albumin, significant correlations with the systemic and hepatic hemodynamic measurements were not observed. Although these parameters may alert the clinician to an underlying cardiac hepatopathy in an at risk individual, they cannot be considered in isolation for predicting the severity of cardiac or hepatic disease.

Page 16: Cardiac hepatopathy.ppt
Page 17: Cardiac hepatopathy.ppt

Discussion -- histologyThe largest to date of histology in living patients with cardiac hepatopathy. The most common histologic features included sinusoidal dilatation, and centrilobular and periportal fibrosis. Other common findings were centrilobular necrosis, atrophy, hemorrhage, inflammation, and periportal necrosis. These changes varied with the temporal course of cardiac dysfunction.Patients with acute cardiac dysfunction were more likely to show centrilobular damage, presumably reflecting the vulnerability of this region to acute ischemic insult. In contrast, there was a trend toward increased fibrosis and distorted hepatic architecture in those with long-standing cardiac dysfunction.

Page 18: Cardiac hepatopathy.ppt
Page 19: Cardiac hepatopathy.ppt

Hemodynamics vs Histology

Patients with distorted hepatic architecture caused by fibrosis had higher WHVP reflective of increased portal pressure. Fibrosis per se was not associated significantly with any hemodynamic variable.Dilatation of the central veins and sinusoids, classic features of cardiac hepatopathy, were associated with higher filling pressures. (Arcidi et al., in an autopsy series, reported a similar association between chronic passive congestion and increased right atrial size.) Patients with centrilobular and periportal damage had higher HVPGs and is likely related to hepatocyte swelling. The resultant sinusoidal compression presumably elevates portal pressure by increasing hepatic vascular resistance.

Page 20: Cardiac hepatopathy.ppt

Cardiac cirrhosis

Cardiac cirrhosis continues to be a rare condition.In this series, despite centrilobular fibrosis in three quarters of the patients, only one case of cirrhosis was identified.Although false-negative transjugular liver biopsies must be considered, it appears that with newer methods of treatment of heart failure, cardiac hepatopathy rarely progresses to this severe stage, and/or patients die of their cardiac condition before the development of cirrhosis.

Page 21: Cardiac hepatopathy.ppt

Esophageal varices

Esophagogastric varices are uncommon in this condition. Because varices represent collateral vessels from the high-pressure portal circulation to the low-pressure systemic venous bed, they are unlikely to form in cardiac hepatopathy in which pressures generally remain high along the entire path of venous return to the right atrium. Based on these pathophysiologic considerations, it is possible that the varices observed in a few patients represent either false-positive endoscopies or undetected concomitant disease such as portal vein thrombosis.

Page 22: Cardiac hepatopathy.ppt

Limitation of the study

1. The mixed retrospective-prospective sample collection makes it difficult to draw any conclusions regarding prevalence/incidence.

2. Inclusion of only patients with a compatible liver biopsy may have introduced a selection bias because patients referred for biopsy may have had greater alterations in liver function. This may account for the high prevalence of ascites and jaundice in the patient population.

3. Classification system based on the temporal course of cardiac dysfunction is limited by heterogeneity in the underlying cardiac diagnoses within groups.

4. Hepatitis C virus infection could not be definitively ruled out in patients studied during the 1980s.

5. Numerous between-group comparisons were made without correcting for multiple comparisons, mainly due to the small sample size of this study. As a result, type I errors cannot be excluded and confirmatory studies are warranted.

Page 23: Cardiac hepatopathy.ppt

SummaryThe patients described herein show the diverse manifestations of cardiac hepatopathy, and represent the most rigorously studied population to date. Elevated right-sided cardiac pressures transmitted caudad to the hepatic and portal venous circulations, and a typically normal hepatic venous pressure gradient, are the most salient hemodynamic features. Because the clinical manifestations of this disorder may mimic those of common hepatic conditions, a high index of suspicion is required, particularly in patients with a previous history of cardiac dysfunction.